United Therapeutics Corporation
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.2% | -9.4% | +20.0% | +0.2% | +4.3% | -16.2% | +14.2% | -7.2% | -7.6% | -4.9% | +3.0% | +7.5% | -22.5% | +14.5% | +1.6% | +5.0% | +1.3% | -1.5% | +17.8% | -0.4% | -6.6% | +11.2% | +1.1% | +10.5% | -4.7% | +3.1% | +17.7% | +2.2% | +0.9% | +10.2% | +5.5% | +4.8% | -1.7% | +7.9% | +0.5% | +0.1% | -1.2% | -1.1% | +0.2% | – | |
| – | +20.3% | -49.6% | +32.2% | +3.2% | +171.8% | +0.4% | +16.0% | -15.9% | -38.5% | -8.8% | -8.2% | +23.6% | -12.7% | -18.8% | +10.7% | -7.3% | +45.0% | -33.9% | +61.7% | -25.5% | +24.9% | -25.1% | +14.7% | +25.3% | +50.3% | -6.4% | +22.6% | +9.4% | +1.3% | +2.7% | +6.7% | +6.8% | -8.7% | +21.9% | -5.3% | +15.2% | +2.5% | +29.0% | -25.4% | – | |
| – | -1.0% | -6.4% | +19.5% | +0.1% | -3.4% | -18.4% | +13.9% | -5.7% | -3.1% | -4.6% | +4.0% | +6.2% | -23.4% | +17.9% | +1.0% | +6.0% | -1.7% | +1.7% | +14.9% | +1.9% | -8.7% | +14.6% | +0.3% | +9.5% | -9.0% | +4.4% | +17.1% | +1.3% | +0.8% | +11.2% | +5.3% | +4.5% | -0.9% | +6.3% | +1.3% | -1.7% | -1.7% | -5.6% | +5.5% | – | |
| – | +45.8% | -45.9% | +65.2% | -8.0% | +106.5% | -68.6% | +130.5% | +22.8% | +37.3% | +546.5% | -90.4% | -0.2% | +32.6% | -35.6% | +22.5% | -23.4% | +83.6% | +140.8% | -75.5% | +6.6% | +4.7% | -16.8% | +36.1% | -29.6% | +42.1% | -11.7% | +7.4% | -4.8% | +78.7% | -31.2% | +34.1% | -25.9% | +29.3% | +11.4% | -10.1% | -4.9% | +9.4% | -0.9% | +5.9% | – | |
| – | +37.7% | -62.8% | +26.6% | -39.5% | +350.6% | -85.9% | +239.2% | +63.1% | -56.8% | +64.7% | -67.0% | +226.6% | +2.4% | -7.6% | +16.5% | -42.2% | +163.3% | -27.1% | -7.5% | -4.0% | +21.3% | -42.2% | +94.4% | -35.2% | +76.2% | -50.8% | +56.1% | -2.7% | +1.1% | +12.1% | +25.6% | +30.4% | -31.7% | +5.9% | +11.4% | -3.9% | +2.3% | -1.1% | -11.3% | – | |
| – | +41.4% | -55.1% | +37.4% | -19.7% | +166.8% | -89.3% | +468.4% | +27.7% | +3.2% | +353.9% | -87.3% | +47.5% | +18.2% | -24.0% | +17.7% | -31.0% | +111.0% | +47.8% | -55.5% | +0.6% | +11.9% | -29.8% | +59.1% | -30.1% | +58.1% | -34.5% | +28.7% | -3.1% | +33.6% | -12.4% | +27.6% | +1.7% | -6.3% | +5.6% | +8.6% | -10.7% | +6.5% | -2.1% | +9.5% | – | |
| – | -27.0% | +51.3% | -66.4% | +265.9% | -57.1% | +120.8% | -29.2% | -31.2% | -12.1% | -598.8% | – | -17.2% | -65.4% | +162.5% | -15.7% | +57.4% | -70.5% | -199.2% | – | +2.9% | -25.8% | +69.6% | -29.9% | +55.7% | -44.1% | +62.0% | +10.2% | +4.3% | -20.5% | +37.0% | -10.2% | +7.3% | +4.3% | +7.0% | -4.8% | +6.8% | -8.2% | -8.9% | +1.5% | – | |
| – | +340.0% | -63.6% | +75.0% | +135.7% | +6.1% | -25.7% | +11.5% | +41.4% | +4.9% | +139.5% | +18.4% | -4.1% | -14.5% | -18.0% | -31.7% | -12.5% | -2.0% | -4.2% | +2.2% | -2.1% | +2.2% | +0.0% | +31.9% | +48.4% | +33.7% | +12.2% | +7.2% | +5.4% | -3.2% | -11.9% | -12.8% | -12.9% | -21.8% | -22.8% | +19.7% | -58.9% | +3.3% | -3.2% | -3.3% | – | |
| – | -28.3% | +53.7% | -83.2% | +625.6% | -56.0% | +119.1% | -29.5% | -35.7% | -34.4% | -807.9% | – | -33.3% | -59.1% | +151.2% | -22.0% | +63.6% | -47.8% | -71.6% | +566.2% | -5.6% | -31.3% | +119.7% | -51.2% | +107.5% | -42.8% | +63.3% | +14.8% | +5.0% | -16.0% | +34.9% | -10.9% | +9.4% | +2.0% | +6.8% | -3.6% | +7.2% | +1.4% | -28.3% | +17.1% | – | |
| – | -20.8% | +38.9% | +17.9% | -55.7% | +174.8% | -47.1% | -30.2% | -25.3% | -20.8% | -686.5% | – | -23.8% | -54.5% | +115.9% | -20.9% | +78.4% | -67.4% | -73.1% | +945.2% | -5.0% | -32.1% | +143.1% | -49.7% | +111.6% | -36.2% | +9.2% | +49.0% | +10.8% | -7.0% | +17.5% | -16.1% | +3.0% | +19.7% | +6.4% | -2.4% | +0.4% | -19.7% | -45.5% | -8.5% | – | |
| – | -31.8% | +61.9% | -131.4% | – | -93.1% | +1,186.8% | -29.3% | -38.4% | -38.7% | -857.4% | – | -35.4% | -60.3% | +161.8% | -22.2% | +59.9% | -42.3% | -71.4% | +509.9% | -5.7% | -31.0% | +113.8% | -51.6% | +106.3% | -44.8% | +82.4% | +7.6% | +3.2% | -18.9% | +41.2% | -9.3% | +11.1% | -2.5% | +6.9% | -3.9% | +9.4% | +7.6% | -24.5% | +21.1% | – | |
| – | -26.6% | +49.6% | +12.4% | +8.3% | -56.5% | +121.6% | -28.4% | -30.5% | -12.5% | -552.9% | – | -15.4% | -60.6% | +132.0% | -15.1% | +53.1% | -65.9% | -37.6% | +371.0% | -5.2% | -17.9% | +79.3% | -48.0% | +97.4% | -40.8% | +61.0% | +13.8% | +4.9% | -14.8% | +31.7% | -9.7% | +8.4% | +1.5% | +3.1% | -0.1% | +6.0% | +1.5% | -26.8% | +16.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.